CAS No.97-44-9,ACETARSONE Suppliers

Products Categories

Pharmaceutical (15)
Others (7)
Organic Chemicals (4)

Basic Information

Molecular Structure:
CAS No.:	97-44-9
Name:	ACETARSONE

Formula:	C8H10 As N O5
Molecular Weight:	275.093
Synonyms:	Arsonicacid, [3-(acetylamino)-4-hydroxyphenyl]- (9CI); m-Arsanilic acid,N-acetyl-4-hydroxy- (7CI,8CI); 190F; 3-Acetamido-4-hydroxybenzenearsonic acid;3-Acetamido-4-hydroxyphenylarsonic acid;3-Acetylamino-4-hydroxyphenyl-1-arsonic acid;3-Acetylamino-4-hydroxyphenylarsonic acid; Acetarsol; Acetarsone;Acetphenarsine; Amarsan; Amoebal; Arsaphen; Arsonine; Chrlich 594; Devegan;Disparicida; Dynarsan; Ehrlich 594; F 190; Fourneau 190; Ginarsol; Goyl;Gynoplix; Kharophen; Kubarsol; Limarsol; Malagride; Mexyl; Monargan;N-Acetyl-4-hydroxy-m-arsanilic acid; NSC 13160; NSC 3247; Nilacid; Oralcid;Orarsan; Osarsal; Osarsol; Osarsole; Osvarsan; Pallicid; Paroxyl; SVC; Sanogyl;Spirocid; Spirozid; Stovarsol; Stovarsolan; Vagisept; Vagoflor
Density:	g/cm³
Melting Point:	220.5°C
Boiling Point:	°Cat760mmHg
Flash Point:	°C
Hazard Symbols:
Risk Codes:	23/25-50/53
Safety:	Poison by ingestion and intravenous routes. Human systemic effects by ingestion: respiratory system, endocrine system, dermatitis, and fever. Human systemic effects by intravaginal route: hallucinations, distorted perceptions, convulsions, nausea or vomiting, decreased urine volume, and fever. Mutation data reported. See also ARSENIC COMPOUNDS. When heated to decomposition it emits very toxic fumes of NO_x and As.
PSA:	106.86000
LogP:	-1.01540

Total:25 Page 1 of 1 1

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 97-44-9

Chemistry

Empirical Formula of Acetarsone (CAS NO.97-44-9): C₈H₁₀AsNO₅
Molecular Weight: 275.0903 g/mol
EINECS: 202-582-3
Structure of Acetarsone (CAS NO.97-44-9):

IUPAC Name: (3-Acetamido-4-hydroxyphenyl)arsonic acid
Canonical SMILES: CC(=O)NC1=C(C=CC(=C1)[As](=O)(O)O)O
InChI: InChI=1S/C8H10AsNO5/c1-5(11)10-7-4-6(9(13,14)15)2-3-8(7)12/h2-4,12H,1H3,(H,10,11)(H2,13,14,15)
InChIKey: ODFJOVXVLFUVNQ-UHFFFAOYSA-N

Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
cat	LDLo	oral	150mg/kg (150mg/kg)	SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Proceedings of the Society for Experimental Biology and Medicine. Vol. 27, Pg. 267, 1930.
man	TDLo	oral	89mg/kg/9D (89mg/kg)	LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES ENDOCRINE: OTHER CHANGES SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"	American Journal of the Medical Sciences. Vol. 174, Pg. 819, 1927.
mouse	LD50	intravenous	180mg/kg (180mg/kg)		U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#03309,
mouse	LD50	oral	4mg/kg (4mg/kg)		Compilation of LD50 Values of New Drugs.
rabbit	LDLo	intravenous	120mg/kg (120mg/kg)		Archives of Dermatology and Syphilology. Vol. 25, Pg. 799, 1932.
rabbit	LDLo	oral	125mg/kg (125mg/kg)	SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Proceedings of the Society for Experimental Biology and Medicine. Vol. 27, Pg. 267, 1930.
rat	LDLo	intravenous	300mg/kg (300mg/kg)		Archives of Dermatology and Syphilology. Vol. 25, Pg. 799, 1932.
rat	LDLo	oral	1200mg/kg (1200mg/kg)		British Journal of Pharmacology and Chemotherapy. Vol. 3, Pg. 44, 1948.
women	LDLo	intravaginal	155mg/kg/2D-I (155mg/kg)	BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" GASTROINTESTINAL: NAUSEA OR VOMITING	British Medical Journal. Vol. 1, Pg. 1282, 1961.
women	LDLo	intravaginal	1576mg/kg/2D- (1576mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED	British Medical Journal. Vol. 2, Pg. 242, 1960.
women	TDLo	oral	86mg/kg/8D (86mg/kg)	LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"	American Journal of the Medical Sciences. Vol. 174, Pg. 819, 1927.

Consensus Reports

ARSENIC and its compounds are on the Community Right-To-Know List.

Safety Profile

Poison by ingestion and intravenous routes. Human systemic effects by ingestion: respiratory system, endocrine system, dermatitis, and fever. Human systemic effects by intravaginal route: hallucinations, distorted perceptions, convulsions, nausea or vomiting, decreased urine volume, and fever. Mutation data reported. See also ARSENIC COMPOUNDS. When heated to decomposition it emits very toxic fumes of NO_x and As.
Hazard Codes of Acetarsone (CAS NO.97-44-9): Toxic T, Dangerous N
Risk Statements: 23/25-50/53
R23/25:Toxic by inhalation and if swallowed.
R50/53:Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Safety Statements: 20/21-28-45-60-61
S20:When using, do not eat or drink.
S21:When using do not smoke.
S28:After contact with skin, wash immediately with plenty of soap-suds.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S60:This material and its container must be disposed of as hazardous waste.
S61:Avoid release to the environment. Refer to special instructions / safety data sheets.

Standards and Recommendations

OSHA PEL: TWA 500 µg(As)/m³
ACGIH TLV: BEI: 35 μ (As)/L inorganic ARSENIC and methylated metabolites in urine

Specification

Acetarsone , its cas register number is 97-44-9. It also can be called Acid Leather Acetarsol ; Acetamino-hydroxyphenyl-arsonsaeure ; and 3-Acetamido-4-hydroxy-phenylarsonic acid .